Related Experiment Video
Updated: Feb 6, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Contribution of artificial intelligence to the imaging diagnosis of pediatric pulmonary tuberculosis
Roberta Feijó Carvalho1, Sandra Valéria Coelho da Silva1, Michely Alexandrino de Souza Pinheiro1
1Universidade Federal do Rio de Janeiro, Instituto de Puericultura e Pediatria Martagão Gesteira, Rio de Janeiro, Rio de Janeiro, Brazil.
Insights
AI tool CAD4TB shows promise as a complementary screening tool for pediatric tuberculosis (TB) in Brazil. While not recommended for standalone use, it may aid diagnosis in areas lacking radiologists.
Area of Science:
- Medical Imaging
- Artificial Intelligence in Medicine
- Pediatric Infectious Diseases
Background:
- Pediatric tuberculosis (TB) diagnosis presents significant challenges globally and in Brazil.
- The Brazilian Ministry of Health utilizes a clinical scoring system (S-MoH) for suspected pediatric TB, often requiring specialist interpretation of radiographs.
- AI systems like CAD4TB are WHO-approved for adult TB screening but lack recommendations for children under 15.
Purpose of the Study:
- To evaluate the performance of CAD4TBv7.1 as a screening tool for pediatric TB in Brazil.
- To compare CAD4TBv7.1 performance against microbiological confirmation and the S-MoH scoring system.
- To assess the potential of AI as a complementary diagnostic aid in pediatric TB.
Main Methods:
- A retrospective study analyzed 179 chest radiographs from patients aged 0-14 years with suspected pulmonary TB.
- CAD4TBv7.1 was used to analyze radiographs, with two Youden's index-derived cutoff points applied for comparison.
- Results were benchmarked against microbiological confirmation and the S-MoH score.
Main Results:
- CAD4TBv7.1 achieved an Area Under the ROC Curve (AUROC) of 0.71 against microbiological diagnosis (sensitivity 52%, specificity 86.3%).
- Against the S-MoH score, CAD4TBv7.1 showed an AUROC of 0.59 (sensitivity 34.43%, specificity 86.44%).
- The AI demonstrated low sensitivity but high specificity, indicating potential as a screening tool.
Conclusions:
- CAD4TBv7.1 shows potential as a complementary screening tool for pediatric TB, particularly in resource-limited settings.
- Standalone use of CAD4TBv7.1 in children under 15 is not yet recommended.
- Further pediatric validation and integration with clinical approaches are necessary for effective AI implementation in pediatric TB diagnosis.
Abstract:
Pediatric tuberculosis (TB) remains a diagnostic challenge in Brazil and worldwide. The Brazilian Ministry of Health recommends a clinical scoring system (S-MoH) for children and adolescents with suspected TB. Interpretation of radiographs within this scoring system may require specialist input. AI-based systems, such as CAD4TB (Delft Imaging Systems B.V.), approved by the WHO for adults, are not yet recommended for standalone use in children under 15 years of age. A retrospective study was conducted at a pediatric institute from January 31, 2017, to January 29, 2025, including 179 patients aged 0-14 years with pulmonary TB or other diseases. CAD4TBv7.1 analyzed chest radiographs using two cutoff points established by Youden's index: 53.48 for analyses against the S-MoH score and 53.89 for analyses against microbiological confirmation. Results were compared with both microbiological confirmation and S-MoH score. Among the 179 participants, 61 (34.1%) had TB, 25 of which were microbiologically confirmed. CAD4TBv7.1 showed an area under the ROC curve (AUROC) of 0.71, with a sensitivity of 52% and a specificity of 86.3% compared with microbiological diagnosis. Against S-MoH, AUROC was 0.59, with a sensitivity of 34.43% and a specificity of 86.44%. CAD4TBv7.1 demonstrated low sensitivity and high specificity, particularly regarding its overall discriminative capacity. Thus, CAD4TBv7.1 emerges as a promising complementary screening tool for pediatric TB. Although its standalone use is not yet recommended, it may complement S-MoH in settings lacking radiologists. Investments in AI must be accompanied by consistent pediatric validation and strategies that combine technological innovation with traditional and cost-effective clinical approach.
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

